Stockreport

Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives

Portage Biotech Inc.  (PRTG) 
PDF WESTPORT, Conn., April 12, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therap [Read more]